FIBROMATOSIS

作品数：27被引量：46H指数：3
导出分析报告
相关领域：医药卫生更多>>
相关作者：刘慧杨曦何晓光朱鹰路红更多>>
相关机构：昆明医科大学苏州市吴中人民医院天津市肿瘤医院南昌大学第一附属医院更多>>
相关期刊：《Chinese Medical Journal》《Chinese Medical Sciences Journal》《Open Journal of Obstetrics and Gynecology》《World Journal of Dermatology》更多>>
相关基金：国家自然科学基金World Health Organization更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 基金=World Health Organizationx
共 条 记 录，以下是1-1
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects被引量：4
《Frontiers of Medicine》2019年第4期427-437,共11页Zhen Wang Jianhui Wu Xiuyun Tian Chunyi Hao 
We would like to thank all faculty members who assisted us in this study. This work was supported by the Beijing Municipal Administration of Hospitals Clinical Medicine Development Special Funding Support (No. XMLX201708);the Capital Health Research and Development Special Funds (No. 2016-2-2151);Beijing Municipal Administration of Hospitafs Ascent Plan (No. DFL20181104);the National Natural Science Foundation of China (No. 31770836).
Desmoid-type fibromatosis (DF) is a rare monoclonal fibroblastic proliferation that is characterized by locally infiltrative but rarely metastatic lesions. Tyrosine kinase and γ-secretase inhibitors are primarily use...
关键词：targeted therapy desmoid-type FIBROMATOSIS TYROSINE KINASE INHIBITOR Γ-SECRETASE INHIBITOR 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部